HR7749-119

In Committee

Quantum in Practice Act

119th Congress Introduced Mar 2, 2026

Summary

What This Bill Does

The Quantum in Practice Act consists of congressional findings about the potential value of quantum computing for molecular modeling and simulation. Congress states that quantum systems may eventually let scientists model chemical elements and reactions faster and more accurately than existing supercomputers.

The findings identify possible applications: lower-energy synthetic fertilizer production modeled on bacterial nitrogen fixation, more effective medicines with fewer harmful interactions, higher-capacity batteries, lighter and stronger metals, more durable protective gear for law enforcement or military personnel, and new superconductors. The text does not direct an agency to act, authorize funding, create a grant or research program, set a standard, or regulate any private party.

Who Benefits and How

No actor receives a direct legal or financial benefit from this findings-only section. Quantum molecular-modeling researchers, fertilizer developers, pharmaceutical researchers, battery developers, metals manufacturers, protective-equipment suppliers, and superconductor researchers are identified as possible future beneficiaries if the described scientific advances occur. The mechanism is congressional recognition of potential use cases, not an appropriation or mandate.

Who Bears the Burden and How

No federal agency, research institution, company, worker, or taxpayer is assigned a new cost, reporting duty, compliance requirement, or appropriation. Congress does not require the identified industries to develop or use quantum tools. Any research expense or commercial risk would arise from later voluntary activity or future legislation, not from this bill's operative text.

Key Provisions

  • Finds that quantum computing could advance molecular modeling beyond current supercomputers.
  • Identifies bacterial nitrogen fixation as a model for lower-cost synthetic fertilizer development.
  • Identifies drug effectiveness and reduced harmful interactions as possible medical uses.
  • Identifies stronger battery technologies as a possible energy-storage use.
  • Identifies lighter metals and more durable protective equipment as possible materials uses.
  • Identifies new superconductors as another potential application.
  • Creates no program, grant, appropriation, regulatory standard, report, or implementation deadline.

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.

At a Glance

What This Bill Does

Records congressional findings about potential uses of quantum molecular simulation in fertilizer, medicine, batteries, metals, protective equipment, and superconductors without creating a program, funding stream, or legal requirement.

Key Policy Areas

Quantum Computing, Scientific Research, Agriculture, Healthcare, Energy Storage, Advanced Materials

Primary Purpose

Records congressional findings about potential uses of quantum molecular simulation in fertilizer, medicine, batteries, metals, protective equipment, and superconductors without creating a program, funding stream, or legal requirement.

Policy Domains

Quantum Computing Scientific Research Agriculture Healthcare Energy Storage Advanced Materials

Section 2 findings on quantum molecular simulation

Identified Gains
  • Quantum molecular-modeling researchers
  • Synthetic fertilizer developers
  • Pharmaceutical researchers
  • Battery technology developers
  • Advanced metals manufacturers
  • Protective-equipment suppliers
  • Superconductor researchers
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: ih
Pharmaceutical researchers:
Superconductor researchers:
Advanced metals manufacturers:
Battery technology developers:
Protective-equipment suppliers:
Synthetic fertilizer developers:
Quantum molecular-modeling researchers:
Identified Costs
  • No implementing federal agency
  • No regulated research institution
  • No obligated private company
  • No appropriated federal account
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: ih
No obligated private company:
No implementing federal agency:
No appropriated federal account:
No regulated research institution:

Legislative Progress

In Committee
Introduced Committee Passed
Mar 2, 2026

Referred to the House Committee on Science, Space, and Technology.

Mar 2, 2026

Introduced in House

Mar 2, 2026

Mr. Feenstra (for himself, Ms. Stevens, Mr. Valadao, Mrs. Miller-Meeks, …

Stakeholder Effects

cui bono?

How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.

Research & Science
1 mention across 1 clause
?1 uncertain

Quantum molecular-modeling researchers

1/3
sections analyzed
Full impact breakdown

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Quantum Computing Scientific Research Agriculture Healthcare Energy Storage Advanced Materials
Actor Mappings
"congress"
→ Congress issuing nonbinding findings
"researchers"
→ Scientists using quantum molecular simulation

Key Definitions

Terms defined in this bill

1 term
"quantum molecular simulation use cases" §2

The nonbinding fertilizer, medication, battery, metals, protective-equipment, and superconductor applications identified in the findings.

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology